Evidence map›Paper›PMID 27876780›Full record

SynthesisScientific reports2016

A Meta-analysis of MBL2 Polymorphisms and Tuberculosis Risk.

Mohammed Y Areeshi, Raju K Mandal, Naseem Akhter, Sajad A Dar, Arshad Jawed, Mohd Wahid, Harishankar Mahto, Aditya K Panda, Mohtashim Lohani, Shafiul Haque

Abstract readMeta-AnalysisReview
In one paragraph

Synthesis in Scientific reports, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Observational
  3. Review
  4. Article
  5. Review
  6. Article
  7. Association ofFrontiers in immunology · 2020
    Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Mohammed Y AreeshiResearch and Scientific Studies Unit, College of Nursing &Allied Health Sciences, Jazan University, Jazan-45142, Saudi Arabia.
Raju K MandalResearch and Scientific Studies Unit, College of Nursing &Allied Health Sciences, Jazan University, Jazan-45142, Saudi Arabia.
Naseem AkhterDepartment of Laboratory Medicine, Faculty of Applied Medical Sciences, Albaha University, Albaha-65431, Saudi Arabia.
Sajad A DarResearch and Scientific Studies Unit, College of Nursing &Allied Health Sciences, Jazan University, Jazan-45142, Saudi Arabia.
Arshad JawedResearch and Scientific Studies Unit, College of Nursing &Allied Health Sciences, Jazan University, Jazan-45142, Saudi Arabia.
Mohd WahidResearch and Scientific Studies Unit, College of Nursing &Allied Health Sciences, Jazan University, Jazan-45142, Saudi Arabia.
Harishankar MahtoCentre for Life Sciences, Central University of Jharkhand, Ranchi-835205, Jharkhand, India.
Aditya K PandaCentre for Life Sciences, Central University of Jharkhand, Ranchi-835205, Jharkhand, India.
Mohtashim LohaniResearch and Scientific Studies Unit, College of Nursing &Allied Health Sciences, Jazan University, Jazan-45142, Saudi Arabia.
Shafiul HaqueResearch and Scientific Studies Unit, College of Nursing &Allied Health Sciences, Jazan University, Jazan-45142, Saudi Arabia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

MBL2 gene encodes mannose-binding lectin, is a member of innate immune system. Earlier studies revealed that MBL2 gene variants, rs1800451, rs1800450, rs5030737, rs7096206, rs11003125 and rs7095891 are associated with impaired serum level and susceptibility to TB, but their results are inconsistent. A meta-analysis was performed by including 22 studies (7095 TB-patients and 7662 controls) and data were analyzed with respect to associations between alleles, genotypes and minor allele carriers to evaluate the potential association between MBL2 polymorphisms and TB risk. Statistically significant results were found only for the homozygous variant genotype (CC vs. AA: p = 0.045; OR = 0.834, 95% CI = 0.699 to 0.996) of rs1800451 and showed reduced risk of TB in overall population. However, other genetic models of rs1800450, rs5030737, rs7096206, rs11003125, rs7095891 and combined rs1800450, rs1800451, rs5030737 polymorphisms of MBL2 gene did not reveal any association with TB risk. Stratified analysis by ethnicity showed decreased risk of TB in African population for rs1800450 and rs1800451. Whereas, no association was observed between other MBL2 polymorphisms and TB risk in all the evaluated ethnic populations. In conclusion, MBL2 rs1800450 and rs1800451 polymorphisms play a protective role in TB infection and reinforce their critical significance as a potential genetic marker for TB resistance.

Indexed as

AllelesGenetic Predisposition to DiseaseGenotypePolymorphism, GeneticFemaleHumansMaleMannose-Binding LectinRisk FactorsTuberculosisMannose-Binding LectinMBL2 protein, human

Identifiers

PMID27876780
PMCPMC5120291

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.